Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
15.25
-0.41 (-2.62%)
Oct 2, 2025, 4:00 PM EDT - Market closed
Tectonic Therapeutic Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$79.17
Upside
+419.15%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $80 | Buy | Initiates | $80 | +424.59% | Sep 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $64 | Strong Buy | Initiates | $64 | +319.67% | Jul 21, 2025 |
| Raymond James | Raymond James | Buy Initiates $76 | Buy | Initiates | $76 | +398.36% | Jun 11, 2025 |
| Mizuho | Mizuho | Buy Maintains $51 → $85 | Buy | Maintains | $51 → $85 | +457.38% | May 15, 2025 |
| Mizuho | Mizuho | Buy Initiates $51 | Buy | Initiates | $51 | +234.43% | Apr 21, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $112 → $101 | Buy | Maintains | $112 → $101 | +562.30% | Mar 21, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $79 → $112 | Buy | Maintains | $79 → $112 | +634.43% | Jan 31, 2025 |
| Raymond James | Raymond James | Buy Initiates $65 | Buy | Initiates | $65 | +326.23% | Nov 20, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $55 → $79 | Buy | Maintains | $55 → $79 | +418.03% | Nov 12, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $49 → $69 | Buy | Maintains | $49 → $69 | +352.46% | Nov 11, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $55 | Buy | Initiates | $55 | +260.66% | Aug 22, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $49 | Buy | Initiates | $49 | +221.31% | Jul 24, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $76 | Buy | Initiates | $76 | +398.36% | Jun 26, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jun 24, 2024 |